echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Immunity: Yogurt is not harmless!

    Immunity: Yogurt is not harmless!

    • Last Update: 2022-04-22
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Yogurt has a history of nearly 5,000 years as a daily drink for people
    .


    It is rich in lactic acid bacteria, protein, calcium, carbohydrates and various trace elements


    However, not long ago, this kind of healthy food that people thought was "harmless to humans and animals" was labeled as a "cancer accomplice"
    .


    A new study shows that lactic acid bacteria, a type of bacteria thought to promote gut health, can promote tumor growth by affecting the metabolism of tryptophan and thus the function of macrophages


    The study, published in the journal Immunity in February this year, is titled " Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity ", which is translated into Chinese as "tryptophan-derived microbial metabolites".
    Activation of aryl hydrocarbon receptors in tumor-associated macrophages to suppress antitumor immunity"
    .


    The research team is from the University of Toronto School of Medicine


    Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity

    Figure 1 Research results (Source: Immunity)

    Figure 1 Research results (Source: Immunity)

    This work focuses on studying the inverse association of the microbiome with cancer and shows that under certain circumstances, the components of the microbiome may negatively impact cancer treatment
    .


    We examined the effect of AHR (aryl hydrocarbon receptor) on associated macrophage (TAM) function in pancreatic ductal adenocarcinoma (PDAC)


    In long-term PDAC survivors, increased microbiome diversity correlates with TME (tumor-associated macrophage) survival and immunological profile
    .


    Reported fecal transplantation studies in mouse models have also shown that the microbiota can promote or inhibit tumor progression and affect TME cell composition


    And, pan-cancer analysis showed that patients with PDAC (pancreatic ductal adenocarcinoma) exhibited higher AHR compared to most cancer types
    .


    In PDAC patients, high AHR expression is associated with rapid disease progression, mortality, and an immunosuppressive TAM phenotype


    The authors further note that first-in-human clinical trials targeting AHR have been initiated in patients with advanced solid lung, colorectal, and urothelial tumors to examine the presence of AHR inhibition in multiple cancer types
    .


    Ultimately, these trials will provide a definitive test of whether AHR is a legitimate target for cancer treatment


    Although pancreatic cancer is relatively rare, it is the third most deadly cancer in Canada
    .


    Over the past three decades, patients with the disease have not seen the same improved survival seen with other cancers


    Overall, the specific mechanism by which Lactobacillus promotes cancer growth can be described as follows: Lactobacillus metabolizes tryptophan to indole, a metabolite produced by tryptophan metabolism that activates AHR
    .
    AHR is also a component of macrophages.
    As immune cells of the human body, macrophages play an important role in tumor growth and metastasis
    .
    Therefore, the higher the AHR expression, the smaller the inhibitory effect on tumor growth
    .

    The yogurt we often drink contains a lot of lactic acid bacteria.
    Although these probiotics are very helpful to our intestinal health, at the same time, this is also a kind of bacteria that has a potential threat to our body.
    It deserves people's attention
    .

    Original source:

    Original source:

    Hezaveh K, Shinde RS, Kl? tgen A, et al.
    Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
    Immunity.
    2022 Feb 8;55(2):324-340.
    e8.
    doi: 10.
    1016/j .
    immuni.
    2022.
    01.
    006.
    PMID: 35139353; PMCID: PMC8888129.

    leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.